RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Chitosan reinforced alginate controlled release beads of losartan potassium: design, formulation and in vitro evaluation

      한글로보기

      https://www.riss.kr/link?id=A105007198

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The work investigates the development andoptimization of chitosan-alginate beads containing Losartanpotassium (LP) through ionotropic/external gelationtechnique using 32 factorial design. The effect of polymerblendconcentrations i.e. chitosan and sodi...

      The work investigates the development andoptimization of chitosan-alginate beads containing Losartanpotassium (LP) through ionotropic/external gelationtechnique using 32 factorial design. The effect of polymerblendconcentrations i.e. chitosan and sodium alginate onthe drug encapsulation efficiency (DEE%), and cumulativedrug release after 20 h (R20h %) was optimized. The DEE%of all these beads was within the range of 67.12 ±1.97–89.81 ± 1.52 % with sustained in vitro drug releaseof 80.98–97.13 % over 20 h. The in vitro drug release fromthese beads was followed first order kinetic model. Thebeads were also characterized by FE-SEM, FTIR and XRDanalysis. The swelling of chitosan–alginate beads containingLP were influenced by the pH of the test medium.
      Chitosan coated alginate beads were developed as oralsustained delivery carriers for LP in order to improvepatient compliance, to reduce side effects associated with itand also to reduce the dose/dosing frequency in the managementof hypertension.

      더보기

      참고문헌 (Reference)

      1 NIST, "e Handbook of statistical methods"

      2 USP-NF, "The official compendia of standards"

      3 Pasparakis G, "Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads" 323 : 34-42, 2006

      4 Xiudong L, "Swelling behaviour of alginate–chitosan microcapsules prepared by external gelation or internal gelation technology" 56 : 459-464, 2004

      5 Sriamornsak P, "Swelling and diffusion studies of calcium polysaccharide gels intended for film coating" 358 (358): 205-213, 2008

      6 Lee OS, "Studies on the pHdependent swelling properties and morphologies of chitosan/calcium-alginate complexed beads" 198 : 2971-2976, 1997

      7 Shruti C, "Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design" 66 : 73-82, 2007

      8 Gombotz WR, "Protein release from alginate matrices" 31 : 267-285, 1998

      9 Yongmei X, "Preparation of dual crosslinked alginate–chitosan blends gel beads and in vitro controlled release in oral site-specific drug delivery system" 336 : 329-337, 2007

      10 Murata Y, "Preparation of chitosan-reinforced alginate beads-effects of chitosan on gel matrix erosion" 96 : 139-145, 1993

      1 NIST, "e Handbook of statistical methods"

      2 USP-NF, "The official compendia of standards"

      3 Pasparakis G, "Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads" 323 : 34-42, 2006

      4 Xiudong L, "Swelling behaviour of alginate–chitosan microcapsules prepared by external gelation or internal gelation technology" 56 : 459-464, 2004

      5 Sriamornsak P, "Swelling and diffusion studies of calcium polysaccharide gels intended for film coating" 358 (358): 205-213, 2008

      6 Lee OS, "Studies on the pHdependent swelling properties and morphologies of chitosan/calcium-alginate complexed beads" 198 : 2971-2976, 1997

      7 Shruti C, "Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design" 66 : 73-82, 2007

      8 Gombotz WR, "Protein release from alginate matrices" 31 : 267-285, 1998

      9 Yongmei X, "Preparation of dual crosslinked alginate–chitosan blends gel beads and in vitro controlled release in oral site-specific drug delivery system" 336 : 329-337, 2007

      10 Murata Y, "Preparation of chitosan-reinforced alginate beads-effects of chitosan on gel matrix erosion" 96 : 139-145, 1993

      11 Ga°serØd O, "Microcapsules of alginate–chitosan. II. A study of capsule stability and permeability" 20 : 773-783, 1999

      12 Ga°serØd O, "Microcapsules of alginate–chitosan. I. A quantitative study of the interaction between alginate and chitosan" 19 : 1815-1825, 1998

      13 Patil JS, "Ionotropic gelation and polyelectrolyte complexation: the novel techniques to design hydrogel particulate sustained, modulated drug delivery system: a review" 5 : 241-248, 2010

      14 Singh B, "Gastro retentive floating sterculia–alginate beads for use in antiulcer drug delivery" 88 : 997-1012, 2010

      15 Marc H, "Foye’s principle of medicinal chemistry" Wolters Kluwer (India) Pvt Ltd 754-755, 2008

      16 Naik JB, "Formulation and evaluation of repaglinide nanoparticles as a sustained release carriers" 1 (1): 259-266, 2012

      17 Fwu LM, "Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent" 48 : 61-72, 2002

      18 Nayak AK, "Develpment of pH-sensitive tamarind seed polysaccharide alginate composite beads for controlled diclofenac sodium delivery using response surface methodology" 49 : 784-793, 2011

      19 Malakar J, "Development of cloxacillin loaded multiple-unit alginate-based floating system by emulsion–gelation method" 50 : 138-147, 2012

      20 Sezer AD, "Controlled release of piroxicam from chitosan beads" 121 : 113-116, 1995

      21 Anil KA, "Chitosan–alginate multilayer beads for controlled release of ampicillin" 290 : 45-54, 2005

      22 Remun˜an LC, "Chitosan microspheres for the specific delivery of amoxicillin to the gastric cavity" 10 : 69-76, 2000

      23 Illum L, "Chitosan and its use as a pharmaceutical excipient" 15 : 1326-1331, 1998

      24 SmidsrØd O, "Alginate as immobilization matrix for cells" 8 : 71-78, 1990

      25 Gacesa P, "Alginate" 8 : 161-182, 1988

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-06-09 학술지명변경 한글명 : 약제학회지 -> Journal of Pharmaceutical Investigation
      외국어명 : Jorunal of Korean Pharmaceutical Sciences -> Journal of Pharmaceutical Investigation
      KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-06-16 학회명변경 영문명 : The Korean Society Of Pharmaceutics -> The Korean Society of Pharmaceutical Sciences and Technology KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.14
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.11 0.374 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼